<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02999282</url>
  </required_header>
  <id_info>
    <org_study_id>2441</org_study_id>
    <nct_id>NCT02999282</nct_id>
  </id_info>
  <brief_title>Rehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects</brief_title>
  <acronym>ReRescuePGR</acronym>
  <official_title>Rehabilitative Trial for the Recovery of Neurophysiological Parameters in Progranulin Mutation Carriers Through the Use of Transcranial Direct Current Stimulation (tDCS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Spedali Civili di Brescia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized, double-blind, sham-controlled study, the investigators will evaluate the
      effects of frontal and prefrontal anodal transcranial direct current stimulation (tDCS) on
      neurophysiological parameters of cortical connectivity, assessed by transcranial magnetic
      stimulation (TMS), in asymptomatic subjects at risk and symptomatic patients bearing a
      pathogenic Progranulin mutation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized, double-blind, sham-controlled study, the investigators will evaluate the
      effects of frontal and prefrontal anodal transcranial magnetic stimulation (tDCS) on
      neurophysiological parameters of cortical connectivity, assessed by transcranial magnetic
      stimulation (TMS), in asymptomatic subjects at risk and symptomatic patients bearing a
      pathogenic Progranulin mutation.

      All patients will undergo genetic screening for progranulin mutations, a baseline
      neuropsychological and neurophysiological evaluation, including assessment of short interval
      intracortical inhibition, intracortical facilitation, short interval intracortical
      facilitation and long interval intracortical inhibition. Subjects will then be randomized in
      two groups, one receiving a 10 day (5 days/week for 2 weeks) treatment with anodal frontal
      and prefrontal anodal tDCS and the other receiving sham stimulation with identical
      parameters. After the intervention, patients will be reassessed with a neuropsychological and
      neurophysiological evaluation at 2 weeks, 3 months and 6 month after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 31, 2016</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in SICI measurements from Baseline</measure>
    <time_frame>Baseline - 2 weeks</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical inhibition (SICI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in ICF measurements from Baseline</measure>
    <time_frame>Baseline - 2 weeks</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on intracortical facilitation (ICF).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in SICF measurements from Baseline</measure>
    <time_frame>Baseline - 2 weeks</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical facilitation (SICF).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in LICI measurements from Baseline</measure>
    <time_frame>Baseline - 2 weeks</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on long interval intracortical inhibition (LICI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in SICI measurements from Baseline</measure>
    <time_frame>Baseline - 1 month - 3 months</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical inhibition (SICI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ICF measurements from Baseline</measure>
    <time_frame>Baseline - 1 month - 3 months</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on intracortical facilitation (ICF).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SICF measurements from Baseline</measure>
    <time_frame>Baseline - 1 month - 3 months</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical facilitation (SICF).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in LICI measurements from Baseline</measure>
    <time_frame>Baseline - 1 month - 3 months</time_frame>
    <description>By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on long interval intracortical inhibition (LICI).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Frontotemporal Dementia</condition>
  <condition>GRN Related Frontotemporal Dementia</condition>
  <arm_group>
    <arm_group_label>Pretreated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Asymptomatic subjects - 10 days anodal transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preuntreated</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Asymptomatic subjects - 10 days sham transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FTDtreated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Symptomatic patients - 10 days anodal transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FTDuntreated</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Symptomatic patients - 10 days sham transcranial direct current stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anodal transcranial direct current stimulation</intervention_name>
    <description>10 sessions of anodal transcranial direct current stimulation (5 days/week for 2 weeks)</description>
    <arm_group_label>Pretreated</arm_group_label>
    <arm_group_label>FTDtreated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcranial direct current stimulation</intervention_name>
    <description>10 sessions of sham transcranial direct current stimulation (5 days/week for 2 weeks)</description>
    <arm_group_label>Preuntreated</arm_group_label>
    <arm_group_label>FTDuntreated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients bearing a pathogenic mutation in the Progranulin gene

        Exclusion Criteria:

          -  Severe head trauma in the past

          -  History of seizures

          -  History of ischemic stroke or hemorrhage

          -  Pacemaker

          -  Metal implants in the head/neck region

          -  Severe comorbidity

          -  Intake of illegal drugs

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Borroni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Spedali Civili, Brescia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Borroni, MD</last_name>
    <phone>+39 030 3995631</phone>
    <email>barbara.borroni@unibs.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Azienda Ospedaliera Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Benussi A, Cosseddu M, Filareto I, Dell'Era V, Archetti S, Sofia Cotelli M, Micheli A, Padovani A, Borroni B. Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. Ann Neurol. 2016 Sep;80(3):472-6. doi: 10.1002/ana.24731. Epub 2016 Aug 10.</citation>
    <PMID>27438089</PMID>
  </reference>
  <reference>
    <citation>Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet L, Fregni F, Fritsch B, Gillick B, Hamilton RH, Hampstead BM, Jankord R, Kirton A, Knotkova H, Liebetanz D, Liu A, Loo C, Nitsche MA, Reis J, Richardson JD, Rotenberg A, Turkeltaub PE, Woods AJ. Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul. 2016 Sep-Oct;9(5):641-661. doi: 10.1016/j.brs.2016.06.004. Epub 2016 Jun 15. Review.</citation>
    <PMID>27372845</PMID>
  </reference>
  <reference>
    <citation>Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, Di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015 Jun;126(6):1071-107. doi: 10.1016/j.clinph.2015.02.001. Epub 2015 Feb 10. Review.</citation>
    <PMID>25797650</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2016</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Spedali Civili di Brescia</investigator_affiliation>
    <investigator_full_name>Barbara Borroni</investigator_full_name>
    <investigator_title>Associated Professor; MD</investigator_title>
  </responsible_party>
  <keyword>TMS</keyword>
  <keyword>tDCS</keyword>
  <keyword>Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

